FP prostanoid receptor activation of a T-cell factor/β-catenin signaling pathway

被引:54
作者
Fujino, H [1 ]
Regan, JW [1 ]
机构
[1] Univ Arizona, Coll Pharm, Dept Pharmacol & Toxicol, Tucson, AZ 85721 USA
关键词
D O I
10.1074/jbc.C100039200
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
FP prostanoid receptors are G-protein-coupled receptors (GPCR) that consist of two known isoforns, FPA and FPB. These isoforms, which are generated by alternative mRNA splicing, are identical except for their carboxyl-terminal domains. Previously we have shown that stimulation of both isoforms with prostaglandin F-2 alpha (PGF(2 alpha)) activates the small G-protein Rho, leading to morphological changes consisting of cell rounding and the formation of cell aggregates. Following the removal of PGF(2 alpha), however, FPA-expressing cells show rapid reversal of cell rounding, whereas FPB-expressing cells do not. We now show that acute treatment of FPB-expressing cells with PGF(2 alpha) leads to a subcellular reorganization of beta -catenin, a decrease in the phosphorylation of cytoplasmic beta -catenin, and persistent stimulation of Tcf/Lef-mediated transcriptional activation. This does not occur in FPA-expressing cells and may underlie the differences between these isoforms with respect to the reversal of cell rounding. The Tcf/beta -catenin signaling pathway is known to mediate the actions of Wnt acting through the heptahelical receptor, Frizzled, and has not been associated previously with GPCR activation. Our findings expand the signaling possibilities for GPCRs and suggest novel roles for FP receptors in normal tissue development and malignant transformation.
引用
收藏
页码:12489 / 12492
页数:4
相关论文
共 26 条
[1]   beta-catenin is a target for the ubiquitin-proteasome pathway [J].
Aberle, H ;
Bauer, A ;
Stappert, J ;
Kispert, A ;
Kemler, R .
EMBO JOURNAL, 1997, 16 (13) :3797-3804
[2]  
Barker N, 2000, ADV CANCER RES, V77, P1
[3]   Functional interaction of beta-catenin with the transcription factor LEF-1 [J].
Behrens, J ;
vonKries, JP ;
Kuhl, M ;
Bruhn, L ;
Wedlich, D ;
Grosschedl, R ;
Birchmeier, W .
NATURE, 1996, 382 (6592) :638-642
[4]   Wnt signaling: a common theme in animal development [J].
Cadigan, KM ;
Nusse, R .
GENES & DEVELOPMENT, 1997, 11 (24) :3286-3305
[5]   INHIBITION OF GLYCOGEN-SYNTHASE KINASE-3 BY INSULIN-MEDIATED BY PROTEIN-KINASE-B [J].
CROSS, DAE ;
ALESSI, DR ;
COHEN, P ;
ANDJELKOVICH, M ;
HEMMINGS, BA .
NATURE, 1995, 378 (6559) :785-789
[6]  
Dale TC, 1998, BIOCHEM J, V329, P209
[7]   Delayed reversal of shape change in cells expressing FPB prostanoid receptors -: Possible role of receptor resensitization [J].
Fujino, H ;
Pierce, KL ;
Srinivasan, D ;
Protzman, CE ;
Krauss, AH ;
Woodward, DF ;
Regan, JW .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2000, 275 (38) :29907-29914
[8]   EICOSANOIDS AND MULTISTAGE CARCINOGENESIS IN NMRI MOUSE SKIN - ROLE OF PROSTAGLANDIN-E AND PROSTAGLANDIN-F IN CONVERSION (1ST STAGE OF TUMOR PROMOTION) AND PROMOTION (2ND STAGE OF TUMOR PROMOTION) [J].
FURSTENBERGER, G ;
GROSS, M ;
MARKS, F .
CARCINOGENESIS, 1989, 10 (01) :91-96
[9]   Axin, a negative regulator of the Wnt signaling pathway, forms a complex with GSK-3β and β-catenin and promotes GSK-3β-dependent phosphorylation of β-catenin [J].
Ikeda, S ;
Kishida, S ;
Yamamoto, H ;
Murai, H ;
Koyama, S ;
Kikuchi, A .
EMBO JOURNAL, 1998, 17 (05) :1371-1384
[10]   Constitutive transcriptional activation by a beta-catenin-Tcf complex in APC(-/-) colon carcinoma [J].
Korinek, V ;
Barker, N ;
Morin, PJ ;
vanWichen, D ;
deWeger, R ;
Kinzler, KW ;
Vogelstein, B ;
Clevers, H .
SCIENCE, 1997, 275 (5307) :1784-1787